2015
DOI: 10.3109/02688697.2015.1012051 View full text |Buy / Rent full text
|
|

Abstract: The intraoperative use of carmustine wafers in combination with Stupp regimen is a viable first-line treatment option of glioblastomas. The prognostic value of this treatment association should be evaluated in a multicenter trial, ideally in a randomized and placebo-controlled one.

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
7
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals